Could this Healthcare Stock really climb 199.75% in 2023?

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Lithium Arms Race: Tech Revolutionizes Extraction]( [Learn What this means to the Lithium Starved World Economy]( --------------------------------------------------------------- August 7, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Investors have all eyes on the "Jewel Of The Lithium Triangle."]( young company with seasoned leadership and substantial investors has placed itself smack dab in Argentina. They're surrounded by multi-billion dollar lithium producers and established infrastructure in the coveted "Jewel Of The Lithium Triangle." [See what this means to Investors]( --------------------------------------------------------------- [Eli Lilly & Co]( Symbol: [LLY]( Recent Price: $449.49 Average Analyst Price Target: $360.82 (13.47%) Market Cap: $426.69B Last Year's EPS: $2.09 Consensus EPS Forecast: $1.73 Expected Earnings Date: Aug 08 2023 Recent Analyst Action: Evan Seigerman, analyst at BMO Capital, reiterates coverage on [Eli Lilly & Co (LLY)]( in the Healthcare sector with a Buy rating and a price target of $565 (1 week ago). [TipRanks.com]( also reports that [Eli Lilly & Co]( currently has 20 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $360.82 . The target pricing ranges from a high forecast of $455.00 down to a low forecast of $236.00. [Eli Lilly & Co (LLY)](’s last closing price was $449.49 which would put the average price target at 13.47% upside. Here are 3rd party ratings for [LLY](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 28% (70 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Get Access to Adam O'Dell's New AI Stock Rating System]( O’Dell, a pioneer in AI investing, is opening the doors to his patent pending stock rating system. The same system that predicted the crash of Silicon Valley Bank, Wayfair, Carvana and Beyond Meat months in advance — just released its newest findings. [Details here…]( --------------------------------------------------------------- [Zoetis]( Symbol: [ZTS]( Recent Price: $178.63 Average Analyst Price Target: $239.25 (17.94%) Market Cap: $82.55B Last Year's EPS: $1.15 Consensus EPS Forecast: $1.26 Expected Earnings Date: Aug 08 2023 Recent Analyst Action: Michael Ryskin, analyst at Bank of America Securities, reiterates coverage on [Zoetis (ZTS)]( in the Healthcare sector with a Buy rating and a price target of $200 (1 week ago). [TipRanks.com]( also reports that [Zoetis]( currently has 12 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $239.25 . The target pricing ranges from a high forecast of $254.00 down to a low forecast of $225.00. [Zoetis (ZTS)](’s last closing price was $178.63 which would put the average price target at 17.94% upside. Here are 3rd party ratings for [ZTS](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 33% (84 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Insulet]( Symbol: [PODD]( Recent Price: $263.14 Average Analyst Price Target: $309.58 (29.66%) Market Cap: $18.34B Last Year's EPS: $0.24 Consensus EPS Forecast: $0.09 Expected Earnings Date: Aug 08 2023 Recent Analyst Action: Joanne Wuensch, analyst at Citi, reiterates coverage on [Insulet (PODD)]( in the Healthcare sector with a Hold rating and a price target of $319 (4 weeks ago). [TipRanks.com]( also reports that [Insulet]( currently has 14 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $309.58 . The target pricing ranges from a high forecast of $350.00 down to a low forecast of $250.00. [Insulet (PODD)](’s last closing price was $263.14 which would put the average price target at 29.66% upside. Here are 3rd party ratings for [PODD](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 44% (110 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Prepare Now For This $20.6 Trillion AI Wealth Transfer]( to Silicon Valley Insider Luke Lango, we could be on the verge of the biggest wealth transfer in history. He says: “The ChatGPT craze could create 4 million new millionaires in the next 7 years.” [Click here now see how to prepare for this $20.6 trillion shift.]( --------------------------------------------------------------- [New Fortress Energy]( Symbol: [NFE]( Recent Price: $28.23 Average Analyst Price Target: $56.00 (49.49%) Market Cap: $5.79B Last Year's EPS: $0.3 Consensus EPS Forecast: $0.82 Expected Earnings Date: Aug 08 2023 Recent Analyst Action: Benjamin Nolan, analyst at Stifel Nicolaus, reiterates coverage on [New Fortress Energy (NFE)]( in the Energy sector with a Buy rating and a price target of $49 (5 days ago). [TipRanks.com]( also reports that [New Fortress Energy]( currently has 13 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $56.00 . The target pricing ranges from a high forecast of $68.00 down to a low forecast of $44.00. [New Fortress Energy (NFE)](’s last closing price was $28.23 which would put the average price target at 49.49% upside. Here are 3rd party ratings for [NFE](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Strong Sell, Bottom 15% (214 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Luminar Technologies]( Symbol: [LAZR]( Recent Price: $7 Average Analyst Price Target: $16.00 (85.71%) Market Cap: $2.64B Last Year's EPS: -$0.26 Consensus EPS Forecast: -$0.24 Expected Earnings Date: Aug 08 2023 Recent Analyst Action: Itay Michaeli, analyst at Citi, reiterates coverage on [Luminar Technologies (LAZR)]( in the Technology sector with a Buy rating and a price target of $18 (2 months ago). [TipRanks.com]( also reports that [Luminar Technologies]( currently has 14 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $16.00 . The target pricing ranges from a high forecast of $21.00 down to a low forecast of $8.00. [Luminar Technologies (LAZR)](’s last closing price was $7 which would put the average price target at 85.71% upside. Here are 3rd party ratings for [LAZR](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 43% (110 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Mysterious Invisible Railroad Projects Are Popping Up Everywhere...]( the heels of successful tests in Germany, Italy and Sweden, the world’s first large-scale… fully-commercial… public-ready invisible railroad is coming to U.S. this July. But [this city]( is only the tip of the spear. I expect dozens of more projects to soon commence — in states like Pennsylvania, Utah, and Florida — resulting in upwards of $900 million in corporate profits for one tiny pioneer trading for less than $20. [Go here to learn more.]( --------------------------------------------------------------- [Payoneer]( Symbol: [PAYO]( Recent Price: $4.92 Average Analyst Price Target: $7.83 (78.86%) Market Cap: $1.77B Last Year's EPS: -$0.03 Consensus EPS Forecast: $0.031 Expected Earnings Date: Aug 08 2023 Recent Analyst Action: Unknown Analyst, analyst at Northland Securities, reiterates coverage on [Payoneer (PAYO)]( in the Financial sector with a Buy rating and a price target of $10 (3 weeks ago). [TipRanks.com]( also reports that [Payoneer]( currently has 13 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $7.83 . The target pricing ranges from a high forecast of $10.00 down to a low forecast of $6.50. [Payoneer (PAYO)](’s last closing price was $4.92 which would put the average price target at 78.86% upside. Here are 3rd party ratings for [PAYO](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Sell, Top 44% (109 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Arvinas Holding Company]( Symbol: [ARVN]( Recent Price: $24.02 Average Analyst Price Target: $82.50 (199.75%) Market Cap: $1.28B Last Year's EPS: -$1.56 Consensus EPS Forecast: -$1.46 Expected Earnings Date: Aug 08 2023 Recent Analyst Action: Matthew Biegler, analyst at Oppenheimer, reiterates coverage on [Arvinas Holding Company (ARVN)]( in the Healthcare sector with a Buy rating and a price target of $95 (1 month ago). [TipRanks.com]( also reports that [Arvinas Holding Company]( currently has 12 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $82.50 . The target pricing ranges from a high forecast of $123.00 down to a low forecast of $49.00. [Arvinas Holding Company (ARVN)](’s last closing price was $24.02 which would put the average price target at 199.75% upside. Here are 3rd party ratings for [ARVN](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 43% (107 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [A Single Investor Placed a $10+ Million Bet On a Young Company]( Lithium legend has placed a multi-million dollar bet on a young company smack in the middle of multi-billion dollar lithium producers. This Lithium asset is so valuable, a major industrial company is effectively trying to steal it. [See why this small company is getting so much attention.]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software